• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗心律失常试验中的死亡分类。

Classification of death in antiarrhythmia trials.

作者信息

Epstein A E, Carlson M D, Fogoros R N, Higgins S L, Venditti F J

机构信息

Department of Medicine, University of Alabama at Birmingham 35294-0006, USA.

出版信息

J Am Coll Cardiol. 1996 Feb;27(2):433-42. doi: 10.1016/0735-1097(95)00482-3.

DOI:10.1016/0735-1097(95)00482-3
PMID:8557917
Abstract

OBJECTIVES

We sought to develop and apply a new scheme for the classification of death to be used in trials of antiarrhythmia treatments.

BACKGROUND

Because presently accepted classifications of death do not fully describe or tabulate all significant aspects of terminal events, nor do they consider unique aspects of arrhythmia investigations, a new classification scheme that addresses these issues is desirable.

METHODS

A classification scheme of deaths that occur in antiarrhythmia trials was developed using the following categories: 1) primary organ cause (cardiac [arrhythmic, nonarrhythmic or unknown], noncardiac or unknown); 2) temporal course (sudden, nonsudden or unknown); 3) documentation (witnessed, monitored [yes, no or unknown]); 4) operative relation (preoperative, perioperative or postoperative); and 5) system relation (procedure related, pulse generator related and lead related [yes, no or unknown]).

RESULTS

The classification scheme was used in a clinical trial of a new implantable cardioverter-defibrillator (1,250 patients, of whom 79 died) and used in an application for device market approval. Application of the classification to data reported using an older classification scheme is demonstrated.

CONCLUSIONS

We propose a descriptive classification scheme that 1) fully describes and tabulates all significant aspects of terminal events; 2) incorporates previously used categorizations of death and new categorizations that address unique aspects of arrhythmia investigations; and 3) tabulates sufficient data to allow comparison with other studies. Events in a clinical trial of implantable defibrillator therapy were classified using the new classification scheme.

摘要

目的

我们试图开发并应用一种新的死亡分类方案,用于抗心律失常治疗试验。

背景

由于目前公认的死亡分类并未充分描述或列表呈现终末事件的所有重要方面,也未考虑心律失常研究的独特方面,因此需要一种解决这些问题的新分类方案。

方法

使用以下类别制定抗心律失常试验中发生死亡的分类方案:1)主要器官病因(心脏[心律失常性、非心律失常性或不明]、非心脏性或不明);2)时间进程(突然、非突然或不明);3)记录情况(有目击者、监测到[是、否或不明]);4)手术相关性(术前、围手术期或术后);5)系统相关性(与手术操作相关、与脉冲发生器相关和与导线相关[是、否或不明])。

结果

该分类方案用于一项新型植入式心脏复律除颤器的临床试验(1250例患者,其中79例死亡),并用于设备上市批准申请。展示了将该分类应用于使用旧分类方案报告的数据的情况。

结论

我们提出一种描述性分类方案,该方案:1)充分描述并列表呈现终末事件的所有重要方面;2)纳入了先前使用的死亡分类以及针对心律失常研究独特方面的新分类;3)列表呈现足够的数据以便与其他研究进行比较。使用新分类方案对植入式除颤器治疗临床试验中的事件进行了分类。

相似文献

1
Classification of death in antiarrhythmia trials.抗心律失常试验中的死亡分类。
J Am Coll Cardiol. 1996 Feb;27(2):433-42. doi: 10.1016/0735-1097(95)00482-3.
2
Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials.心脏性猝死分类准确性的探索。对临床试验解读的启示。
Circulation. 1996 Feb 1;93(3):519-24. doi: 10.1161/01.cir.93.3.519.
3
Adjudication of mortality events in a heart failure-arrhythmia trial by a multiparameter descriptive method: comparison with methods used in heart failure trials and methods used in arrhythmia trials.
J Interv Card Electrophysiol. 2008 Nov;23(2):101-10. doi: 10.1007/s10840-008-9277-3. Epub 2008 Jul 4.
4
Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.抗心律失常药物与植入式除颤器(AVID)试验中的死亡原因。
J Am Coll Cardiol. 1999 Nov 1;34(5):1552-9. doi: 10.1016/s0735-1097(99)00376-9.
5
Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery.
Circulation. 1999 Mar 23;99(11):1416-21. doi: 10.1161/01.cir.99.11.1416.
6
Classification of sudden and arrhythmic death.猝死和心律失常性死亡的分类。
Pacing Clin Electrophysiol. 1997 Oct;20(10 Pt 2):2545-52. doi: 10.1111/j.1540-8159.1997.tb06103.x.
7
Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study).
Am J Cardiol. 1989 Jan 1;63(1):1-6. doi: 10.1016/0002-9149(89)91065-5.
8
Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.由于起搏诱导性心肌病而升级为心脏再同步治疗的患者发生危及生命的室性心律失常的风险较低:一项长期死因分析。
Europace. 2018 Jan 1;20(1):89-96. doi: 10.1093/europace/euw321.
9
Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators.第三代植入式心脏复律除颤器患者的心脏性死亡与存储的心电信号
J Am Coll Cardiol. 1998 Oct;32(4):1056-62. doi: 10.1016/s0735-1097(98)00359-3.
10
Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis.植入式除颤器预防心律失常事件和死亡的有效性:一项荟萃分析。
J Am Coll Cardiol. 2003 May 7;41(9):1573-82. doi: 10.1016/s0735-1097(03)00253-5.

引用本文的文献

1
Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.生命末期植入式心脏转复除颤器管理的时间趋势:病历回顾性研究。
Eur J Cardiovasc Nurs. 2019 Aug;18(6):449-457. doi: 10.1177/1474515119844660. Epub 2019 Apr 17.
2
Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.用于非缺血性心肌病患者的植入式心脏除颤器。
Cochrane Database Syst Rev. 2018 Dec 8;12(12):CD012738. doi: 10.1002/14651858.CD012738.pub2.
3
The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review.
植入式心脏复律除颤器电击在生命末期的发生率及影响:一项综合综述。
Eur J Cardiovasc Nurs. 2018 Aug;17(6):477-485. doi: 10.1177/1474515118777421. Epub 2018 May 18.
4
The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy.慢性肾脏病对心脏再同步治疗死亡率的影响。
Pacing Clin Electrophysiol. 2016 Aug;39(8):863-9. doi: 10.1111/pace.12883. Epub 2016 Jun 7.
5
Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial.植入式心脏复律除颤器患者的术中除颤测试及临床电击疗效:北欧植入式心脏复律除颤器随机临床试验
Eur Heart J. 2015 Oct 1;36(37):2500-7. doi: 10.1093/eurheartj/ehv292. Epub 2015 Jun 25.
6
Sudden cardiac death: time to make a difference: Pro ICD.心脏性猝死:是时候做出改变了:预防性植入式心律转复除颤器
Neth Heart J. 2006 Dec;14(12):417-419.
7
EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors.EAARN评分,一种基于植入前危险因素对接受心脏再同步治疗患者死亡率的预测评分。
Eur J Heart Fail. 2014 Jul;16(7):802-9. doi: 10.1002/ejhf.102. Epub 2014 May 23.
8
Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol.多中心自动除颤器植入试验:减少不适当治疗(MADIT-RIT):背景、原理及临床方案
Ann Noninvasive Electrocardiol. 2012 Jul;17(3):176-85. doi: 10.1111/j.1542-474X.2012.00531.x.
9
ADHD drugs and serious cardiovascular events in children and young adults.注意缺陷多动障碍药物与儿童和青年严重心血管事件。
N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.
10
Detection of myocardial damage in patients with sarcoidosis.结节病患者心肌损伤的检测
Circulation. 2009 Nov 17;120(20):1969-77. doi: 10.1161/CIRCULATIONAHA.109.851352. Epub 2009 Nov 2.